Voisine C - Search Results

1

A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease.

Brehme M, Voisine C, Rolland T, Wachi S, Soper JH, Zhu Y, Orton K, Villella A, Garza D, Vidal M, Ge H, Morimoto RI. Brehme M, et al. Among authors: voisine c. Cell Rep. 2014 Nov 6;9(3):1135-50. doi: 10.1016/j.celrep.2014.09.042. Epub 2014 Oct 23. Cell Rep. 2014. PMID: 25437566 Free PMC article.

2

Chaperone networks: tipping the balance in protein folding diseases.

Voisine C, Pedersen JS, Morimoto RI. Voisine C, et al. Neurobiol Dis. 2010 Oct;40(1):12-20. doi: 10.1016/j.nbd.2010.05.007. Epub 2010 May 21. Neurobiol Dis. 2010. PMID: 20472062 Free PMC article. Review.

3

Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.

Brehme M, Voisine C. Brehme M, et al. Among authors: voisine c. Dis Model Mech. 2016 Aug 1;9(8):823-38. doi: 10.1242/dmm.024703. Dis Model Mech. 2016. PMID: 27491084 Free PMC article. Review.

4

Arylazanylpyrazolone derivatives as inhibitors of mutant superoxide dismutase 1 dependent protein aggregation for the treatment of amyotrophic lateral sclerosis.

Zhang Y, Benmohamed R, Huang H, Chen T, Voisine C, Morimoto RI, Kirsch DR, Silverman RB. Zhang Y, et al. Among authors: voisine c. J Med Chem. 2013 Mar 28;56(6):2665-75. doi: 10.1021/jm400079a. Epub 2013 Mar 15. J Med Chem. 2013. PMID: 23445362 Free PMC article.

5

Acetylation targets mutant huntingtin to autophagosomes for degradation.

Jeong H, Then F, Melia TJ Jr, Mazzulli JR, Cui L, Savas JN, Voisine C, Paganetti P, Tanese N, Hart AC, Yamamoto A, Krainc D. Jeong H, et al. Among authors: voisine c. Cell. 2009 Apr 3;137(1):60-72. doi: 10.1016/j.cell.2009.03.018. Cell. 2009. PMID: 19345187 Free PMC article.

6

Caenorhabditis elegans as a model system for triplet repeat diseases.

Voisine C, Hart AC. Voisine C, et al. Methods Mol Biol. 2004;277:141-60. doi: 10.1385/1-59259-804-8:141. Methods Mol Biol. 2004. PMID: 15201454

7

Identification of potential therapeutic drugs for huntington's disease using Caenorhabditis elegans.

Voisine C, Varma H, Walker N, Bates EA, Stockwell BR, Hart AC. Voisine C, et al. PLoS One. 2007 Jun 6;2(6):e504. doi: 10.1371/journal.pone.0000504. PLoS One. 2007. PMID: 17551584 Free PMC article.

8

Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity.

Faber PW, Voisine C, King DC, Bates EA, Hart AC. Faber PW, et al. Among authors: voisine c. Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17131-6. doi: 10.1073/pnas.262544899. Epub 2002 Dec 16. Proc Natl Acad Sci U S A. 2002. PMID: 12486229 Free PMC article.

9

Inhibitors of metabolism rescue cell death in Huntington's disease models.

Varma H, Cheng R, Voisine C, Hart AC, Stockwell BR. Varma H, et al. Among authors: voisine c. Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14525-30. doi: 10.1073/pnas.0704482104. Epub 2007 Aug 28. Proc Natl Acad Sci U S A. 2007. PMID: 17726098 Free PMC article.

10

Selective inhibitors of death in mutant huntingtin cells.

Varma H, Voisine C, DeMarco CT, Cattaneo E, Lo DC, Hart AC, Stockwell BR. Varma H, et al. Among authors: voisine c. Nat Chem Biol. 2007 Feb;3(2):99-100. doi: 10.1038/nchembio852. Epub 2006 Dec 31. Nat Chem Biol. 2007. PMID: 17195849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters